Home > Research Institute > Available Trials > A Phase 2 study of Seribantumab in Patients with Solid Tumors
A Phase 2 study of Seribantumab in Patients with Solid Tumors
A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors
Disease Types: Solid Tumors
Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville
A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors
For More Information:
https://clinicaltrials.gov/ct2/show/NCT04383210?term=ELVCAP-001-01&draw=2&rank=1